Crestor Coupons- Free Printable Crestor Coupons

Print Your Free Crestor Coupons Here
Would you like to save money on your next prescription of Crestor? This Crestor coupons page will help you to save money on your prescriptions for this high cholesterol medication. You will find information, links and resources to help you find coupons to print, promotional coupon codes, manufacturer discounts, rebates, deals and special printable discount offers that will allow you to buy cholesterol lowering medications, as prescribed by your doctor, at your local retail pharmacy and pay less. Rosuvastatin (marketed by AstraZeneca as Crestor) is a member of the drug class of statins, used to treat high cholesterol and related conditions, and to prevent cardiovascular disease.
It was developed by Shionogi.Rosuvastatin is available as Crestor in tablet form (5, 10, 20, or 40 mg) for oral administration. Tablets are pink, round, or oval (40 mg), biconvex, film-coated, and imprinted with "ZD4522" and tablet strength.Japanese approval is in the dose range of 2.5 mg to 20 mg; therefore, smaller-dose tablet forms might also be available outside the United States. Note that 97% of worldwide sales have been at or below the 20 mg dose.In October 2003, several months after its introduction in Europe, Richard Horton, the editor of the medical journal The Lancet, criticized the way Crestor had been introduced. "AstraZeneca's tactics in marketing its cholesterol-lowering drug, rosuvastatin, raise disturbing questions about how drugs enter clinical practice and what measures exist to protect patients from inadequately investigated medicines," according to his editorial.
The Lancet's editorial position is that the data for Crestor's superiority relies too much on extrapolation from the lipid profile data (surrogate endpoints) and too little on hard clinical endpoints, which are available for other statins that had been on the market longer. The manufacturer responded by stating that few drugs had been tested so successfully on so many patients. In correspondence published in The Lancet, AstraZeneca's CEO Sir Tom McKillop called the editorial "flawed and incorrect" and slammed the journal for making "such an outrageous critique of a serious, well-studied medicine."
Print Your Free Crestor Coupons Here